FDA Approves Abbott’s Next-Gen Navitor TAVI System For Aortic Stenosis
The FDA has approved Abbott Laboratories (NYSE:ABT) latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe…
AbbVie, Eli Lilly Leave UK’s Voluntary Medicines Pricing Agreement Over Increasing Prices
The Association of the British Pharmaceutical Industry (ABPI) said pharmaceutical giants AbbVie Inc (NYSE:ABBV) and Eli Lilly And Co (NYSE:LLY) have withdrawn from Britain’s…
Amid Sluggish Sales In China, Alibaba Rolls Out ‘Buy Now Pay Later’ Option
Splitit Payments Ltd (OTCQX: SPTTY) and Alipay have
Barron’s Top Weekend Stock Picks: Amazon, Tesla, Disney And Why Big Tech May Be In For A Major Comeback
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Rising Interest Rates Lead To Big Bank Profit Gains: Are There Hints Of Inbound Recession?
Investors waiting for another round of earnings were greeted by Friday’s reports from the nation’s biggest banks showing that profits rose across the sector, boosted by the Federal Reserve’s high-interest rate environment.
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Wells Fargo Beats On Q4 Earnings, But Profits Sink
Wells Fargo & Co (NYSE:WFC) reported a Q4 net income of $2.85 billion, down 53% Y/Y and 20% sequentially, driven…
Big Banks Kick Off Q4 Earnings Season: Why JPMorgan’s Results Suggest Mild 2023 Recession Is The Base Case
Rising interest rates, weak consumer spending, and inflation reaching a four-decade high have all contributed to a tough outlook for the American economy in recent months.
Citigroup Q4 Earnings Miss Expectations, Posts Lower Profits On Provision Hike, Slower Dealmaking
Citigroup Inc’s (NYSE:C) Q4 FY22 net income decreased by more than 21% from a year ago to $2.5 billion. Revenues…